Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2023 | Identifying operational tolerance pathways after SCT & cGvHD immune profiles with machine learning

Kirk Schultz • 23 Apr 2023
EBMT 2023
General

Kirk Schultz, MD, British Columbia Children’s Hospital, Vancouver, Canada, comments on the use of machine learning to identify patterns of immune tolerance or of developing chronic graft-versus-host disease (GvHD) after stem cell transplantation (SCT) in the pediatric ABLE 1.0 study cohort. This interview took place at the 49th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) held in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Kirk Schultz

2:25
GvHD biomarker discovery and validation
Kirk Schultz • 15 Mar 2021
0:46
Tackling GvHD together
Kirk Schultz • 15 Mar 2021
0:41
Abatacept for prevention of acute GVHD
Kirk Schultz • 15 Mar 2021

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals